The funding will be used to complete the Phase II/III trial of ulviprubart, and to support commercial launch preparation.

Dr Nandita Palshetkar, IVF expert and medical director, Bloom IVF, explains how certain behaviour can lead to poor quality of ...

Influenza, COVID-19 and RSV are staples of the winter cold and flu season, but the measles, whooping cough and norovirus are ...

John Bertram Reinitz, a professor in the Departments of Statistics, Ecology and Evolution, Molecular Genetics & Cell Biology ...

Agenus Inc. , a leader in immuno-oncology, today announced that BOT/BAL will be featured in two presentations at the upcoming American Association for Cancer Research (AACR) IO Annual Meeting that ...

Request Sample of the Report on Global Serum Free and Specialty Media Market 2033 - Increase in R&D expenditure in biopharmaceuticals, rise in demand for biologics and monoclonal antibodies, and rise ...

Researchers developed an epigenetic editing approach to silence the PCSK9 gene, achieving long-term cholesterol reduction ...

“The most common food allergens in children include milk, eggs, peanuts, tree nuts (e.g., almonds, cashews), sesame, soy, ...

Researchers determine a complex immune infiltrate pattern based on a newly constructed immune map developed using pancreatic ...

Exelixis, Inc. EXEL reported better-than-expected fourth-quarter results. EXEL recorded earnings of 55 cents per share, which beat the Zacks Consensus Estimate of 51 cents. The company registered ...

Monoclonal antibodies have emerged as a promising approach in the fight against Alzheimer's disease, offering hope for slowing its progression. T ...

Sanofi-backed Abcuro has secured $200 million in series C funds to power its anti-KLRG1 antibody through a phase 2/3 muscle ...